Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Achieve Life Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ACHV
Nasdaq
8731
http://achievelifesciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Achieve Life Sciences Inc
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
- Jun 21st, 2022 12:00 pm
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
- Jun 1st, 2022 12:00 pm
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
- May 26th, 2022 12:00 pm
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
- May 16th, 2022 5:20 pm
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
- May 13th, 2022 12:00 pm
ACHV: First Quarter 2022 Results
- May 13th, 2022 10:30 am
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
- May 12th, 2022 8:00 pm
Health Check: How Prudently Does Achieve Life Sciences (NASDAQ:ACHV) Use Debt?
- May 5th, 2022 6:59 pm
ACHV: Topline Data from ORCA-2 Smoking Cessation Trial
- Apr 28th, 2022 9:22 am
Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation
- Apr 27th, 2022 1:40 pm
Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers
- Apr 27th, 2022 12:00 pm
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
- Apr 21st, 2022 12:00 pm
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
- Mar 15th, 2022 12:00 pm
Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors
- Mar 14th, 2022 12:00 pm
ACHV: 2021 Results: ORCA-3 Underway, ORCA-V1 Soon to Start
- Mar 11th, 2022 1:06 pm
Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award
- Mar 11th, 2022 1:00 pm
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update
- Mar 10th, 2022 1:00 pm
Achieve Life Sciences Announces Participation in March Investor Conferences
- Mar 8th, 2022 1:00 pm
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022
- Feb 24th, 2022 1:00 pm
ACHV: The Final Phase III Begins
- Feb 4th, 2022 9:37 am
Scroll